Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.

Abstract

This review ofpharmacotherapyforfrontotemporal lobar degeneration describes the chemical rationale for agents used and reports observed responses to psychotropic medications. Paroxetine addressed anxiety and repetitive, ritualistic behaviors. Depression was resistant to treatment. Valproic acid and quetiapine calmed agitated subjects without exacerbating Parkinsonism. Donepezil has not emerged as a beneficial medication for this group of subjects. Behavioral disturbances can be alleviatedpharmacologically, but further research might determine guidelines for management of this non-Alzheimer's dementia syndrome that could decrease the frequency of adverse drug events.

Statistics

02040'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

63 Citations

Semantic Scholar estimates that this publication has 63 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Chow2002GoalsIS, title={Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.}, author={Tiffany W. Chow and Mario F. Mendez}, journal={American journal of Alzheimer's disease and other dementias}, year={2002}, volume={17 5}, pages={267-72} }